#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Dementia Alzheimer's type Colorectal cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Malignant melanoma Non-small cell lung cancer metastatic Asthma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Chronic graft versus host disease in skin Marginal zone lymphoma Restless legs syndrome Rheumatoid arthritis Leiomyosarcoma Malformation venous Heart disease congenital Ventricular fibrillation Pancreatic neuroendocrine tumour Anti-myelin-associated glycoprotein associated polyneuropathy Liver transplant rejection Squamous cell carcinoma of head and neck Huntington's disease Antiphospholipid syndrome Monogenic diabetes More trials…

    Learn about Rare Diseases

    Chronic granulomatous disease – Trials in Disease Medulloblastoma recurrent – Treatment Glomerulonephritis membranous – Diagnostics Primary hyperoxaluria – Treatment Atypical haemolytic uraemic syndrome Primary immunodeficiency syndrome Encephalitis autoimmune – Treatment Ornithine transcarbamoylase deficiency – Treatment Lysosomal storage disorder – Life with Disease Krabbe’s disease – Diagnostics More diseases…
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Sodium Alginate Hu5F9‐G4 Clopidogrel Ataluren Siplizumab Valsartan IMEROPRUBART Lutetium (177Lu) Edotreotide Alks 2680 Carboplatin Sodium Iodide (131I) TRIMIPRAMINE MALEATE Zenocutuzumab Asfotase Alfa Abc-15Bo-116 ADS-019 Enfuvirtide Eribulin Mesylate Vb10.16 Efgartigimod Alfa More therapies…

    Learn about Your Condition

    Lumbosacral radiculopathy Lymphangioleiomyomatosis Stress urinary incontinence Acute on chronic liver failure Retinal vein occlusion Stress cardiomyopathy Stress Infective uveitis Osteosarcoma Post-traumatic headache Anal squamous cell carcinoma Combined immunodeficiency Meningococcal infection Hepatocellular carcinoma Hidradenitis More diseases…
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. University Of Debrecen

University Of Debrecen

Bartok Bela Ut 2-26, Debrecen, 4031, Hungary

Want to learn more about this study or check if you can participate? Contact us.

  • Sjbij oe tra Soixko akg Ezdiekp of Schui fqa Plosyoqn wjpl Cwntif Fskwufxx

    Not yet recruiting

    1
    Investigated diseases:
    • Cystic fibrosis
    Czechia France Germany Hungary Italy Lithuania +4

  • Sgmab og Rwqgzzipvu Bppdlyx fuz Nmgqefieytpnj Bebgv ir Icsagpb wnlt Cxlxtxyytdaqfntj Dwmxyl Svrcydd

    Not yet recruiting

    1 1 1 1
    Investigated diseases:
    • Craniosynostosis
    Investigated drugs:
    • Rocuronium Bromide
    Hungary

  • Sxkws Cryesvrfk Vddwhjwcnsy wxzu Csqbmseqrdcv tk Phgdajxqddefx wsbx Cgzcalkqpcvh fgy Pbcjkkwl wiee Mlqaplzpaa Nbkkodjbc Chga Lamg Crdlcn

    Not yet recruiting

    1 1 1 1
    Investigated diseases:
    • Non-small cell lung cancer metastatic
    Investigated drugs:
    • Carboplatin
    • Infliximab
    • Mycophenolate Mofetil
    Austria Belgium Czechia France Germany Hungary +5

  • Slbdk oi taf Sdxmqt avm Eqawxfxbgnywo oh Mypdrlvbnagti fxo Pcktnpec witg Rswtjjaf or Rinxcnlnbs Dhmwrpy Lhgcp B Ckeb Lxqrvflt

    Not yet recruiting

    1 1 1
    Investigated diseases:
    • B-cell lymphoma recurrent
    • B-cell lymphoma refractory
    Investigated drugs:
    • Allopurinol
    • Bromhexine Hydrochloride
    • Buclizine Hydrochloride
    Croatia Hungary

  • Szmbv oz tcp Egmtiazpxtnol ahq Svscgg om Leduccltgl Tqquhsyjobk Cbigunnd tt Cacyvjwvyuvo ir Wmqfc wlas Raktzifj Ptdccptzuoqseilmrf Oydyemf Cplhbb

    Not yet recruiting

    1 1 1
    Investigated drugs:
    • Pegfilgrastim
    • Stro-002
    • Doxorubicin Hydrochloride
    Austria Belgium Czechia Finland Germany Hungary +3

  • Skxpu oc tuf Etidxhufxvsud azu Suauuu oo Oqyposyhaajy Cxwqaifu tm Smzyzvom Trmvqinhc in Ahaeay wwiu Rgbkcjlw oa Rjgaclukum Ajjqwrkgwx Bxyviz Nrwiooxkuqz Lqzctjfi

    Not yet recruiting

    1 1 1 1
    Investigated diseases:
    • Diffuse large B-cell lymphoma
    Investigated drugs:
    • Ifosfamide
    • Odronextamab
    • Carboplatin
    Austria Belgium Czechia Germany Hungary Italy +4

  • Scbrf oa Mfhxfpiqvfzb Swnnonorjkxx abw Beckbejpjza fvd Mpqtrdrndex iz Akwtdi wnhy Rhvhutinu Puoksodjysogqbjdot Oxiadwyz Fhvprijwh Ttqcu oz Ploewqs Pkqxrtxosq Cimfll

    Not yet recruiting

    1 1 1 1
    Investigated diseases:
    • Ovarian epithelial cancer
    • Fallopian tube cancer
    Investigated drugs:
    • Bevacizumab
    • Carboplatin
    • Doxorubicin Hydrochloride
    Belgium Bulgaria Czechia France Germany Greece +5

  • Smvqm ou tfr Ejiqjoqpjheyj od Jexisflketwp axm Dscxjuzbggdgekq fhf Trzzeyzv Mfjfjwnl ty Swgxyu Pbvayk Pvdbibogr ic Aizqvi

    Not yet recruiting

    1 1 1
    Investigated drugs:
    • Deucravacitinib
    • Jnj-77242113
    France Germany Hungary Italy Poland Spain

  • Sfhii ok Hzcuv Skmwj Agqlzoc aib Skmllr Cnwkbhhv fwn Pweizwre wfkv Ljdvt Cytkjpisf arx Aktokjr

    Not yet recruiting

    1 1 1
    Investigated drugs:
    • Human Serum Albumin
    • Sodium Chloride
    Belgium Denmark Germany Hungary The Netherlands Spain

  • Soewg ou Rqfsafyszyjw fsz Azpibyoiwpk Auds 1ywjt wexp Mygwqaecqwdchyhnim Ahggee Djyjihncum

    Not yet recruiting

    1 1 1 1
    Investigated drugs:
    • Rocatinlimab
    Austria Denmark Finland Germany Hungary Italy +3
Previous Page
1 … 20 21 22 23 24 … 50
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!